Cho CH - Search Results

1

Cathelicidins in inflammation and tissue repair: Potential therapeutic applications for gastrointestinal disorders.

Wu WK, Wong CC, Li ZJ, Zhang L, Ren SX, Cho CH. Wu WK, et al. Among authors: cho ch. Acta Pharmacol Sin. 2010 Sep;31(9):1118-22. doi: 10.1038/aps.2010.117. Epub 2010 Aug 2. Acta Pharmacol Sin. 2010. PMID: 20676121 Free PMC article. Review.

2

The host defense peptide LL-37 activates the tumor-suppressing bone morphogenetic protein signaling via inhibition of proteasome in gastric cancer cells.

Wu WK, Sung JJ, To KF, Yu L, Li HT, Li ZJ, Chu KM, Yu J, Cho CH. Wu WK, et al. Among authors: cho ch. J Cell Physiol. 2010 Apr;223(1):178-86. doi: 10.1002/jcp.22026. J Cell Physiol. 2010. PMID: 20054823

3

Macroautophagy and ERK phosphorylation counteract the antiproliferative effect of proteasome inhibitor in gastric cancer cells.

Wu WK, Cho CH, Lee CW, Wu YC, Yu L, Li ZJ, Wong CC, Li HT, Zhang L, Ren SX, Che CT, Wu K, Fan D, Yu J, Sung JJ. Wu WK, et al. Among authors: cho ch. Autophagy. 2010 Feb;6(2):228-38. doi: 10.4161/auto.6.2.11042. Epub 2010 Feb 24. Autophagy. 2010. PMID: 20087064

4

Proteasome inhibition: a new therapeutic strategy to cancer treatment.

Wu WK, Cho CH, Lee CW, Wu K, Fan D, Yu J, Sung JJ. Wu WK, et al. Among authors: cho ch. Cancer Lett. 2010 Jul 1;293(1):15-22. doi: 10.1016/j.canlet.2009.12.002. Epub 2010 Feb 4. Cancer Lett. 2010. PMID: 20133049 Review.

5

Development of peptides as potential drugs for cancer therapy.

Li ZJ, Cho CH. Li ZJ, et al. Among authors: cho ch. Curr Pharm Des. 2010;16(10):1180-9. doi: 10.2174/138161210790945913. Curr Pharm Des. 2010. PMID: 20166989 Review.

6

Cyclooxygenase-2 in tumorigenesis of gastrointestinal cancers: an update on the molecular mechanisms.

Wu WK, Sung JJ, Lee CW, Yu J, Cho CH. Wu WK, et al. Among authors: cho ch. Cancer Lett. 2010 Sep 1;295(1):7-16. doi: 10.1016/j.canlet.2010.03.015. Epub 2010 Apr 8. Cancer Lett. 2010. PMID: 20381235 Review.

7

2,3',4,4',5'-Pentamethoxy-trans-stilbene, a resveratrol derivative, inhibits colitis-associated colorectal carcinogenesis in mice.

Li H, Wu WK, Li ZJ, Chan KM, Wong CC, Ye CG, Yu L, Sung JJ, Cho CH, Wang M. Li H, et al. Among authors: cho ch. Br J Pharmacol. 2010 Jul;160(6):1352-61. doi: 10.1111/j.1476-5381.2010.00785.x. Br J Pharmacol. 2010. PMID: 20590626 Free PMC article.

8

A novel peptide specifically targeting the vasculature of orthotopic colorectal cancer for imaging detection and drug delivery.

Li ZJ, Wu WK, Ng SS, Yu L, Li HT, Wong CC, Wu YC, Zhang L, Ren SX, Sun XG, Chan KM, Cho CH. Li ZJ, et al. Among authors: cho ch. J Control Release. 2010 Dec 20;148(3):292-302. doi: 10.1016/j.jconrel.2010.09.015. Epub 2010 Sep 18. J Control Release. 2010. PMID: 20854857

9

Neurotransmitters, more than meets the eye--neurotransmitters and their perspectives in cancer development and therapy.

Li ZJ, Cho CH. Li ZJ, et al. Among authors: cho ch. Eur J Pharmacol. 2011 Sep 30;667(1-3):17-22. doi: 10.1016/j.ejphar.2011.05.077. Epub 2011 Jun 7. Eur J Pharmacol. 2011. PMID: 21664902 Review.

10

Protective effects of cathelicidin-encoding Lactococcus lactis in murine ulcerative colitis.

Wong CC, Zhang L, Li ZJ, Wu WK, Ren SX, Chen YC, Ng TB, Cho CH. Wong CC, et al. Among authors: cho ch. J Gastroenterol Hepatol. 2012 Jul;27(7):1205-12. doi: 10.1111/j.1440-1746.2012.07158.x. J Gastroenterol Hepatol. 2012. PMID: 22507188

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,505 results

Search Page

Filters